Cerevance

Series-B
cerevance.com Biotech & Healthcare
Total Funding $5M
Latest Round $5M Series-B
Last Announced May 12, 2026
Investors Undisclosed
Decision Makers Profile Active

About Cerevance

Private drug discovery and development company focused on brain diseases.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website cerevance.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @cerevance (249 followers)
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $5,000,000 · Series-B

    cerevance.com

  2. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

  3. Capital Raise

    Raised undisclosed · Series-B

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Cerevance.

Funding History

3 Rounds
Series-B equity · May 12, 2026
$5,000,000 cerevance.com
Series-B equity · Apr 25, 2024
Series-B equity · Feb 13, 2023

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts